Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Investor Relations

BioMarin Pharmaceutical Inc.
San Rafael, California
Start date
Mar 18, 2024

View more

Job Details

Director, Investor Relations BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and affect relatively small numbers of patients, many of whom are children. These conditions are often inherited, difficult to diagnose, progressively debilitating and have few, if any, treatment options. BioMarin will continue to focus on advancing therapies that are the first or best of their kind.

BioMarin’s investor relations’ (IR) team has direct input on company messaging and external communications strategy.  IR works closely across all BioMarin teams including, finance, legal, corporate communications, commercial, research and development and manufacturing, to ensure consistent, accurate messaging and open lines of cross-functional communication.  Come join our team and make a meaningful impact on patients’ lives. Description: You will be an integral part of the team partnering with the Group Vice President in the planning, development, and execution of the IR strategy at BioMarin.  Reporting to the GVP of IR, you will serve as a key member of the team to ensure that BioMarin effectively communicates its mission, value proposition and strategy to drive value creation for all stakeholders.  Essential Duties and Responsibilities 
  • Contribute to the strategy and implementation of an IR program that is aligned with BioMarin’s key enterprise priorities and financial goals
  • Collaborate on messaging to educate the capital markets on BioMarin’s corporate strategy, execution, opportunity set and potential risks
  • Monitor, update and analyze sell-side financial models and valuation frameworks, following up with analysts as needed, to ensure alignment with BioMarin’s financial guidance
  • Accountable for tracking and providing feedback on changes to the shareholder base, investor sentiment, peer performance and capital markets trends
  • As needed, present to executives, employees and/or the Board on IR updates including, Wall Street sentiment and competitive landscape
  • Understand innovative and best-in-class IR strategies and tactics through peer and industry benchmarking
  • Prepare investor presentations, draft press releases, conference call scripts, messaging and Q&A documents
  • Work closely with the finance and legal teams to collaborate on quarterly materials to ensure alignment and accuracy for inclusion in SEC documents
  • Significant focus on investor targeting and tracking
  • Work closely with corporate communications to ensure alignment of PR schedule for updates outside of quarterly financials
Proficiency and Expectations The ideal candidate must have prior experience in investor relations working with a publicly-traded bio-pharmaceutical or healthcare company. Education and General Requirements: 
  • Requires a bachelor’s degree (MBA or other advanced degree preferred) and 12+ years of relevant experience
  • Strong communication, organizational and presentation skills, including writing and editing high-quality materials, as drafting of documents will be required
  • Ability to work cross-functionally in a fast-paced, dynamic environment while maintaining “executive presence” under pressure
  • Creative thinker with an ability to see the big picture, while paying close attention to detail
  • Scientific and financial background is a plus
  • Significant financial modelling experience and advanced PPT skills required
  • Direct biotechnology or pharmaceutical industry successfully managing (a majority of) the Investor Relations function at a public company
  • Highly motivated individual who has proven success in working independently within a fast paced, deadline-driven environment, with limited oversight
  • Confidence in communicating with sophisticated investors, company executives, the scientific community and the media 
  • Eventually, up to 25% travel depending on format/location of investor events

Equal Opportunity Employer/Veterans/Disabled 

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. 


BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert